Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adicet Bio, Inc.

0.9888
-0.0012-0.12%
Post-market: 0.98940.0006+0.06%19:55 EDT
Volume:1.73M
Turnover:1.72M
Market Cap:151.54M
PE:-0.76
High:1.02
Open:1.01
Low:0.9610
Close:0.9900
52wk High:1.54
52wk Low:0.4471
Shares:153.25M
Float Shares:132.00M
Volume Ratio:0.64
T/O Rate:1.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3037
EPS(LYR):-1.3330
ROE:-64.39%
ROA:-36.52%
PB:1.14
PE(LYR):-0.74

Loading ...

Canaccord Genuity Remains a Buy on Adicet Bio (ACET)

TIPRANKS
·
Oct 17

Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of Adi-001 in Treatment-Refractory Rheumatoid Arthritis (Ra)

THOMSON REUTERS
·
Oct 16

Adicet Bio Inc - Preliminary Data From Phase 1 Trial Expected in 2H/2026

THOMSON REUTERS
·
Oct 16

Adicet Bio Is Maintained at Buy by Guggenheim

Dow Jones
·
Oct 08

Guggenheim Sticks to Their Buy Rating for Adicet Bio (ACET)

TIPRANKS
·
Oct 08

Adicet Bio Receives Nasdaq Extension to Regain Compliance After Failing Minimum Bid Price Requirement

Reuters
·
Oct 08

Adicet Bio Announces $80 Million Registered Direct Offering of Common Stock and Pre-Funded Warrants

Reuters
·
Oct 07

Adicet Bio, Inc. Announces $80 Million Registered Direct Offering

THOMSON REUTERS
·
Oct 07

Adicet Bio Announces Positive Phase 1 Results for ADI-001 in Lupus Nephritis and SLE, Plans Pivotal Phase 2 Trial in 2026

Reuters
·
Oct 07

Adicet Bio Inc - Adi-001 Well Tolerated With No Icans Observed

THOMSON REUTERS
·
Oct 07

Adicet Bio Announces Positive Preliminary Data From Adi-001 Phase 1 Study in Patients With Lupus Nephritis (Ln) and Systemic Lupus Erythematosus (Sle)

THOMSON REUTERS
·
Oct 07

Adicet Bio Inc - Plans FDA Meeting in 1Q/2026 for Phase 2 Trial

THOMSON REUTERS
·
Oct 07

Adicet Bio Inc - as of Aug 31, All Patients Show Reductions in Sledai-2K Score

THOMSON REUTERS
·
Oct 07

BRIEF-Adicet Bio Reports Inducement Grant Under Nasdaq Listing Rule

Reuters
·
Oct 01

Adicet Bio Grants Inducement Stock Options to New Hire Under 2022 Inducement Plan

Reuters
·
Oct 01

Adicet Bio Price Target Maintained With a $7.00/Share by Guggenheim

Dow Jones
·
Sep 19

Adicet Bio Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

Reuters
·
Sep 02

Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Aug 30

Adicet Bio Inc. Announces New Inducement Grants and Stock Option Plan for Recent Hires

Reuters
·
Aug 30

Adicet Bio Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 11